Developer docs
API playgroundTry for free, no card

Search company profiles

DR. BÄHLER DROPA

Full company profile

uuid0024p5r

Namestring
DR. BÄHLER DROPA
Legal namestring
DR. BÄHLER DROPA AG
Websiteurl
baehlerdropa.ch
Company typeenum
Private
Founded yearint
1967
Descriptiontext

DR. BÄHLER DROPA AG is a privately held, family-owned Swiss healthcare services company founded in 1967 in Steffisburg by pharmacist couple Giulia and Werner Bähler, with headquarters now at Binzstrasse 38, Zürich. It operates an integrated retail, franchise, and institutional medication-management business across approximately 120 locations in German-speaking Switzerland, employing roughly 2,000 staff including more than 300 apprentices, and reporting under no public ticker (CHE-109.103.351). The portfolio is organized into three operating units: Apotheken & Drogerien Dr. Bähler (company-owned pharmacies and drugstores under the Achillea brand), DROPA Drogerien Apotheken (a franchised network combining ~40 owned locations with ~40 independent franchise partners), and the Schweizer Blisterzentrum — a Swissmedic-certified cleanroom facility operating the most modern fully-automated GMP-compliant blister packaging production line in Switzerland, which produces patient-individualized medication sachets for nursing homes, Spitex home-care organizations, prisons, assisted-living facilities, individual patients, and external pharmacies outside the DBD network. The company runs a structured pharmaceutical training pipeline (Drogist*in and Fachfrau/Fachmann Apotheke apprenticeships, Famulatur, Assistenzstellen, and the Trainee@DBD postgraduate program) producing licensed pharmacists and druggists in a market where pharmacist-licensed dispensing is mandatory. Leadership is anchored by the founding family: Franklin Schatzmann as Chair of the Executive Board, Sandra Schatzmann-Bähler (member of the executive board, head of HR development, daughter of the founders), and Marcel Bähler (location manager), supported by departmental heads for marketing and finance. The company operates without disclosed venture capital, private equity, or public market backing.

Short descriptiontext

DR. BÄHLER DROPA AG is a family-owned Swiss pharmacy and drugstore operator running approximately 120 locations across German-speaking Switzerland through owned (Achillea), franchise (DROPA), and institutional medication-blister-packaging (Schweizer Blisterzentrum) units, serving retail consumers, nursing homes, Spitex organizations, correctional facilities, and external pharmacies.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
251–500
akta.pro rankint
HeadquartersZürich, Switzerland
HQ citystring
Zürich
HQ countrystring
Switzerland
HQ regionstring
Europe
Markets served

Serves global market

Offices3 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
retail pharmacy services, drugstore retail, medication blister packaging, institutional healthcare supply, pharmacy franchise operations
Industry2 codes
PRIMARYHLAFALAA
Retail & Community Pharmacies (Chain/Independent)
Healthcare & Life Sciences/Healthcare Providers & Systems/Pharmacy & Medication Management Services
SECONDARYHLAFALAJ
Medication Adherence, Packaging & Fulfillment Services (Blister/Unit-Dose)
Healthcare & Life Sciences/Healthcare Providers & Systems/Pharmacy & Medication Management Services
NAICS code1 code
  • Pharmacies and Drug Retailers456110
SIC code1 code
  • Retail-Drug Stores And Proprietary Stores5912
Product category
Retail Pharmacy and Drugstore Services
Social media profiles1 record
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model4 records
1Retail Pharmacy and Drugstore Sales
TypeTransaction Fee
Description

Revenue from direct operation of pharmacies and drugstores selling medications, health products, beauty products, and wellness items to end consumers. Company operates approximately 80 owned locations under Achillea and DROPA brands.

baehlerdropa.ch
2Franchise Fees and Royalties
TypeLicensing Royalties
Description

Franchise revenue from approximately 40 DROPA franchise partners who pay fees for brand access, centralized services, purchasing power, marketing support, and operational guidance.

baehlerdropa.ch
3Blister Packaging Services
TypeProfessional Services
Description

Fee-for-service revenue from patient-individualized medication blister packaging provided to nursing homes, Spitex organizations, prisons, assisted living facilities, and individual patients, as well as external pharmacies outside the DBD network.

baehlerdropa.ch
4Institutional Medical Supplies
TypeTransaction Fee
Description

Supply of pharmaceuticals, nursing supplies, and consumables to institutions including nursing homes and Spitex organizations, including billing to insurance providers.

baehlerdropa.ch
Marketing channels8 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels4 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Personnel, Operations, Supply Chain, Marketing or Sales, Technology or R&D, Infrastructure
Pricing details2 tiers
1Blister packaging services for institutions
ModelOtherBilling cadenceMulti-year contract
Notes

Institutional pricing negotiated through service contracts with nursing homes, Spitex organizations, and other healthcare facilities. Individual patient blister packaging services available.

baehlerdropa.ch
2Medical and nursing consumables
ModelUnit PricingBilling cadencePay-as-you-go
Notes

Consumables available for order in small quantities. Materials include port catheters, PICC catheters, peripheral venous catheters, infusion supplies, palliative care materials, and CADD accessories. Orders require prescriber signature for insurance billing.

baehlerdropa.ch
GTM typeB2B and B2C
B2B and B2C
Offering typeServices
Services
Brand1 record
1Schweizer Blisterzentrum
Description

Patient-individual medication blister packaging service for institutions and patients, with GMP-certified production facility.

baehlerdropa.ch
Core offering1 text field

DR. BÄHLER DROPA AG operates a network of approximately 120 pharmacies and drugstores across German-speaking Switzerland under the owned Achillea brand and the DROPA franchise brand, alongside the Schweizer Blisterzentrum which produces patient-individualized medication blister packaging in a Swissmedic-certified cleanroom. The company also delivers institutional pharmaceutical supply, blister packaging, and consulting services to nursing homes, Spitex organizations, prisons, assisted living facilities, and external pharmacies, supported by centralized purchasing, HR, quality assurance, marketing, and management services.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 3 values shown
  • 97% apprenticeship exam pass rate with 18 podium placements (2025)
+2 more records
Product overview1 text field

DR. BÄHLER DROPA AG operates as a Swiss healthcare services company consisting of three interconnected business units: (1) Apotheken & Drogerien Dr. Bähler (own-brand pharmacies and drugstores under the Achillea brand), (2) DROPA Drogerien Apotheken (franchise network with both owned and independent partner locations), and (3) Schweizer Blisterzentrum (individualized medication blister packaging service). The company also provides institutional care solutions for retirement homes and Spitex organizations, and offers comprehensive training programs including apprenticeships (Fachfrau/Fachmann Apotheke, Drogist*in), pharmacy internships (Famulatur, Assistenzzeit), and the Trainee@DBD professional development program. A central service center in Zürich provides administrative, HR, procurement, quality assurance, marketing, and management support to all network locations. The network encompasses approximately 120 locations across German-speaking Switzerland.

Product and service5 records
1Apotheken & Drogerien Dr. Bähler (Achillea)
CategoryRetail pharmacy and drugstore
Description

Company-owned pharmacies and drugstores operating under the Achillea brand (white 'A' in green circle logo), run as independent profit centers with autonomous operational decisions by location managers. Aimed at end consumers seeking pharmacy products, drugstore items, beauty, wellness, and pharmaceutical advice.

2DROPA Drogerien Apotheken
CategoryPharmacy and drugstore franchise network
Description

DROPA franchise network of drugstores and pharmacies combining company-owned locations with independent franchise partners who benefit from the DROPA brand, purchasing power, marketing support, and centralized services. Franchise partners are typically licensed Apotheker*innen and Drogist*innen HF.

3Schweizer Blisterzentrum
CategoryInstitutional pharmaceutical packaging service
Description

Patient-individualized medication blister packaging service producing individually portioned medications in the most modern GMP-compliant production facility in Switzerland, operating from a Swissmedic-certified cleanroom with fully automated lines and photographic quality control. Serves nursing homes, Spitex organizations, prisons, assisted living facilities, individual patients, and external pharmacies outside the DBD network.

4Institutional Care Solutions
CategoryInstitutional pharmaceutical supply and consulting
Description

Comprehensive services for institutional care customers covering pharmaceutical supply, consumables procurement, consultancy, and quality management support. Served via direct sales to nursing homes (Alters- und Pflegeheime) and Spitex organizations for medication delivery, patient-specific dosing, and supply logistics.

5Franchising & Nachfolge
CategoryPharmacy and drugstore franchising services
Description

Franchising and succession planning services for drugstores and pharmacies, including the Franchising-Start-up program that supports entrepreneurs (Apotheker*innen and Drogist*innen HF) without established businesses with startup capital, know-how, and initial-phase operational support under the DROPA brand.

Scale indicator8 records

Each record includes

Type, Value, Description, Source

Partnership2 partners
1Swissmedic (Swiss Agency for Therapeutic Products)
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Swissmedic certification for the Schweizer Blisterzentrum cleanroom facility, ensuring compliance with Swiss pharmaceutical manufacturing standards (GMP). Working processes are Swissmedic certified for medication blister packaging production.

baehlerdropa.ch
2Choose Your Impact (Swiss pharmacy industry initiative)
Strategic tierMinorTypeGTM or Marketing Partner
Description

Industry partnership promoting pharmacy professions and career opportunities in Swiss healthcare. DBD participates in this initiative to attract talent to pharmacy careers.

baehlerdropa.ch
Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Amavita is one of Switzerland's largest pharmacy chains with over 180 locations, directly comparable to DBD's network of ~120 stores. It is part of Galenicare (formerly Galexis pharmacy division) and competes head-to-head in the same Swiss retail pharmacy market.

2BENU Apotheken (Phoenix Group)
TypeBroad incumbent
Description

BENU is a major European pharmacy chain brand with Swiss locations, part of the German Phoenix Group. It competes with DBD in Swiss retail pharmacy and brings broader European scale.

TypeBroad incumbent
Description

Galenicare is the umbrella organization of major Swiss pharmacy chains (Amavita, Sun Store, Coop Vitality), and a division of Galenica. Comparable to DBD at a parent/group level as one of the leading pharmacy retail platform operators in Switzerland.

TypeDirect peer
Description

Medbase is a Swiss healthcare network combining medical centers, pharmacies, and physiotherapy, with locations concentrated in German-speaking Switzerland. Comparable to DBD's institutional care and integrated retail offerings.

TypeOthers
Description

Pharmaprix is a major Canadian pharmacy chain under Loblaw, not a direct Swiss competitor but illustrative of a scaled pharmacy retail platform that compares to DBD in format, services, and institutional partnerships. Included as a thematically related peer for retail pharmacy scale.

TypeEmerging player
Description

DocMorris is a leading online pharmacy and mail-order pharmaceutical platform based in Switzerland, serving the same Swiss end market as DBD but via a different (digital) channel. It is the primary digital disruptor to traditional chains like DBD.

TypeDirect peer
Description

TopPharm is a cooperative-style network of independent Swiss pharmacies with ~120 member locations, a peer to DBD in that it combines a brand, purchasing, and marketing platform with independently operated pharmacies.

8Sun Store SA
TypeDirect peer
Description

Sun Store is another major Swiss pharmacy chain, historically part of the Galenica group, operating discount-format pharmacies across Switzerland. It competes directly with DBD in the retail pharmacy space.

9Well Apotheke (formerly Schlecker/Well)
TypeDirect peer
Description

Well is a Swiss pharmacy chain with locations across the country, part of the same retail pharmacy market. It is a direct comparable to DBD's owned and franchise pharmacy formats.

10Müller Drogeriemärkte (Müller Holding)
TypeDirect peer
Description

Müller operates drugstore and perfumery retail locations in Switzerland, directly comparable to DBD's drugstore (Drogerie) offerings. The two compete in the health, beauty, and wellness retail segment.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers6 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment5 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

Integration10 records

Each record includes

Title, Type, Description, Source

AI maturity
App detail

Has app

Feature3 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles5 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries2 records

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

Compliance3 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

DR. BÄHLER DROPA

Retail Pharmacy and Drugstore Servicesbaehlerdropa.ch

DR. BÄHLER DROPA AG is a family-owned Swiss pharmacy and drugstore operator running approximately 120 locations across German-speaking Switzerland through owned (Achillea), franchise (DROPA), and institutional medication-blister-packaging (Schweizer Blisterzentrum) units, serving retail consumers, nursing homes, Spitex organizations, correctional facilities, and external pharmacies.

What DR. BÄHLER DROPA does

DR. BÄHLER DROPA AG is a privately held, family-owned Swiss healthcare services company founded in 1967 in Steffisburg by pharmacist couple Giulia and Werner Bähler, with headquarters now at Binzstrasse 38, Zürich. It operates an integrated retail, franchise, and institutional medication-management business across approximately 120 locations in German-speaking Switzerland, employing roughly 2,000 staff including more than 300 apprentices, and reporting under no public ticker (CHE-109.103.351). The portfolio is organized into three operating units: Apotheken & Drogerien Dr. Bähler (company-owned pharmacies and drugstores under the Achillea brand), DROPA Drogerien Apotheken (a franchised network combining ~40 owned locations with ~40 independent franchise partners), and the Schweizer Blisterzentrum — a Swissmedic-certified cleanroom facility operating the most modern fully-automated GMP-compliant blister packaging production line in Switzerland, which produces patient-individualized medication sachets for nursing homes, Spitex home-care organizations, prisons, assisted-living facilities, individual patients, and external pharmacies outside the DBD network. The company runs a structured pharmaceutical training pipeline (Drogist*in and Fachfrau/Fachmann Apotheke apprenticeships, Famulatur, Assistenzstellen, and the Trainee@DBD postgraduate program) producing licensed pharmacists and druggists in a market where pharmacist-licensed dispensing is mandatory. Leadership is anchored by the founding family: Franklin Schatzmann as Chair of the Executive Board, Sandra Schatzmann-Bähler (member of the executive board, head of HR development, daughter of the founders), and Marcel Bähler (location manager), supported by departmental heads for marketing and finance. The company operates without disclosed venture capital, private equity, or public market backing.

DR. BÄHLER DROPA firmographics

Firmographics
Name
DR. BÄHLER DROPA
Legal name
DR. BÄHLER DROPA AG
Website
https://baehlerdropa.ch
Company type
Private
Founded year
1967
Operating status
Operating
Headcount range
251–500 employees
Short description
DR. BÄHLER DROPA AG is a family-owned Swiss pharmacy and drugstore operator running approximately 120 locations across German-speaking Switzerland through owned (Achillea), franchise (DROPA), and institutional medication-blister-packaging (Schweizer Blisterzentrum) units, serving retail consumers, nursing homes, Spitex organizations, correctional facilities, and external pharmacies.
Ownership category
akta.pro rank

DR. BÄHLER DROPA industry classification

Industry
Product category
Retail Pharmacy and Drugstore Services
NAICS
Pharmacies and Drug Retailers (456110)
SIC
Retail-Drug Stores And Proprietary Stores (5912)
akta.pro industry
PRIMARYHLAFALAA
Retail & Community Pharmacies (Chain/Independent)
Healthcare & Life Sciences/Healthcare Providers & Systems/Pharmacy & Medication Management Services
SECONDARYHLAFALAJ
Medication Adherence, Packaging & Fulfillment Services (Blister/Unit-Dose)
Healthcare & Life Sciences/Healthcare Providers & Systems/Pharmacy & Medication Management Services

Keywords

  • Retail pharmacy services
  • Drugstore retail
  • Medication blister packaging
  • Institutional healthcare supply
  • Pharmacy franchise operations

Where DR. BÄHLER DROPA is headquartered

Location

Headquarters

HQ city
Zürich
HQ country
Switzerland
HQ region
Europe

Offices3 records

Markets served

DR. BÄHLER DROPA business model

Business model
GTM type
B2B and B2C
Offering type
Services
Cost components
Personnel, Operations, Supply Chain, Marketing or Sales, Technology or R&D, Infrastructure

Revenue model

  1. Retail Pharmacy and Drugstore Sales: Revenue from direct operation of pharmacies and drugstores selling medications, health products, beauty products, and wellness items to end consumers. Company operates approximately 80 owned locations under Achillea and DROPA brands.
  2. Franchise Fees and Royalties: Franchise revenue from approximately 40 DROPA franchise partners who pay fees for brand access, centralized services, purchasing power, marketing support, and operational guidance.
  3. Blister Packaging Services: Fee-for-service revenue from patient-individualized medication blister packaging provided to nursing homes, Spitex organizations, prisons, assisted living facilities, and individual patients, as well as external pharmacies outside the DBD network.
  4. Institutional Medical Supplies: Supply of pharmaceuticals, nursing supplies, and consumables to institutions including nursing homes and Spitex organizations, including billing to insurance providers.

Pricing tiers

ModelBillingPrice
OtherMulti-year contractBlister packaging services for institutions
Unit PricingPay-as-you-goMedical and nursing consumables

Go-to-market motion1 record

Distribution channels4 records

Marketing channels8 records

DR. BÄHLER DROPA product offering

Product offering

Core offering

DR. BÄHLER DROPA AG operates a network of approximately 120 pharmacies and drugstores across German-speaking Switzerland under the owned Achillea brand and the DROPA franchise brand, alongside the Schweizer Blisterzentrum which produces patient-individualized medication blister packaging in a Swissmedic-certified cleanroom. The company also delivers institutional pharmaceutical supply, blister packaging, and consulting services to nursing homes, Spitex organizations, prisons, assisted living facilities, and external pharmacies, supported by centralized purchasing, HR, quality assurance, marketing, and management services.

Product overview

DR. BÄHLER DROPA AG operates as a Swiss healthcare services company consisting of three interconnected business units: (1) Apotheken & Drogerien Dr. Bähler (own-brand pharmacies and drugstores under the Achillea brand), (2) DROPA Drogerien Apotheken (franchise network with both owned and independent partner locations), and (3) Schweizer Blisterzentrum (individualized medication blister packaging service). The company also provides institutional care solutions for retirement homes and Spitex organizations, and offers comprehensive training programs including apprenticeships (Fachfrau/Fachmann Apotheke, Drogist*in), pharmacy internships (Famulatur, Assistenzzeit), and the Trainee@DBD professional development program. A central service center in Zürich provides administrative, HR, procurement, quality assurance, marketing, and management support to all network locations. The network encompasses approximately 120 locations across German-speaking Switzerland.

Differentiator

Problem solved

Functional benefit

Brands

  • Schweizer Blisterzentrum: Patient-individual medication blister packaging service for institutions and patients, with GMP-certified production facility.

Products and services

  • Apotheken & Drogerien Dr. Bähler (Achillea) Company-owned pharmacies and drugstores operating under the Achillea brand (white 'A' in green circle logo), run as independent profit centers with autonomous operational decisions by location managers. Aimed at end consumers seeking pharmacy products, drugstore items, beauty, wellness, and pharmaceutical advice.
  • DROPA Drogerien Apotheken DROPA franchise network of drugstores and pharmacies combining company-owned locations with independent franchise partners who benefit from the DROPA brand, purchasing power, marketing support, and centralized services. Franchise partners are typically licensed Apotheker*innen and Drogist*innen HF.
  • Schweizer Blisterzentrum Patient-individualized medication blister packaging service producing individually portioned medications in the most modern GMP-compliant production facility in Switzerland, operating from a Swissmedic-certified cleanroom with fully automated lines and photographic quality control. Serves nursing homes, Spitex organizations, prisons, assisted living facilities, individual patients, and external pharmacies outside the DBD network.
  • Institutional Care Solutions Comprehensive services for institutional care customers covering pharmaceutical supply, consumables procurement, consultancy, and quality management support. Served via direct sales to nursing homes (Alters- und Pflegeheime) and Spitex organizations for medication delivery, patient-specific dosing, and supply logistics.
  • Franchising & Nachfolge Franchising and succession planning services for drugstores and pharmacies, including the Franchising-Start-up program that supports entrepreneurs (Apotheker*innen and Drogist*innen HF) without established businesses with startup capital, know-how, and initial-phase operational support under the DROPA brand.

Quantifiable outcome

  • 97% apprenticeship exam pass rate with 18 podium placements (2025)
  • +2 more outcomes

Companies that use DR. BÄHLER DROPA

Customer profile

Named customers6 records

Segments5 records

Ideal customer profiles3 records

DR. BÄHLER DROPA technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Integration10 records

Feature3 records

DR. BÄHLER DROPA partnerships and signals

Strategic signal

Partnerships

Two partnerships are on record, tiered core and minor.

  • Swissmedic (Swiss Agency for Therapeutic Products)coreStrategic or Co-development PartnerSwissmedic certification for the Schweizer Blisterzentrum cleanroom facility, ensuring compliance with Swiss pharmaceutical manufacturing standards (GMP). Working processes are Swissmedic certified for medication blister packaging production.
  • Choose Your Impact (Swiss pharmacy industry initiative)minorGTM or Marketing PartnerIndustry partnership promoting pharmacy professions and career opportunities in Swiss healthcare. DBD participates in this initiative to attract talent to pharmacy careers.

Scale indicators8 records

Recent moves6 records

Expansion highlights6 records

DR. BÄHLER DROPA competitors and assessment

Company assessment

Direct peers

  • Amavita SA: Amavita is one of Switzerland's largest pharmacy chains with over 180 locations, directly comparable to DBD's network of ~120 stores. It is part of Galenicare (formerly Galexis pharmacy division) and competes head-to-head in the same Swiss retail pharmacy market.
  • Medbase AG: Medbase is a Swiss healthcare network combining medical centers, pharmacies, and physiotherapy, with locations concentrated in German-speaking Switzerland. Comparable to DBD's institutional care and integrated retail offerings.
  • TopPharm AG: TopPharm is a cooperative-style network of independent Swiss pharmacies with ~120 member locations, a peer to DBD in that it combines a brand, purchasing, and marketing platform with independently operated pharmacies.
  • Sun Store SA: Sun Store is another major Swiss pharmacy chain, historically part of the Galenica group, operating discount-format pharmacies across Switzerland. It competes directly with DBD in the retail pharmacy space.
  • Well Apotheke (formerly Schlecker/Well): Well is a Swiss pharmacy chain with locations across the country, part of the same retail pharmacy market. It is a direct comparable to DBD's owned and franchise pharmacy formats.
  • Müller Drogeriemärkte (Müller Holding): Müller operates drugstore and perfumery retail locations in Switzerland, directly comparable to DBD's drugstore (Drogerie) offerings. The two compete in the health, beauty, and wellness retail segment.

Broad incumbents

  • BENU Apotheken (Phoenix Group): BENU is a major European pharmacy chain brand with Swiss locations, part of the German Phoenix Group. It competes with DBD in Swiss retail pharmacy and brings broader European scale.
  • Galenicare AG: Galenicare is the umbrella organization of major Swiss pharmacy chains (Amavita, Sun Store, Coop Vitality), and a division of Galenica. Comparable to DBD at a parent/group level as one of the leading pharmacy retail platform operators in Switzerland.

Others

  • Pharmaprix (Shoppers Drug Mart / Loblaw): Pharmaprix is a major Canadian pharmacy chain under Loblaw, not a direct Swiss competitor but illustrative of a scaled pharmacy retail platform that compares to DBD in format, services, and institutional partnerships. Included as a thematically related peer for retail pharmacy scale.

Emerging players

  • DocMorris AG (formerly Zur Rose): DocMorris is a leading online pharmacy and mail-order pharmaceutical platform based in Switzerland, serving the same Swiss end market as DBD but via a different (digital) channel. It is the primary digital disruptor to traditional chains like DBD.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks5 records

Key highlights6 records

Customer concentration

DR. BÄHLER DROPA social profiles

Digital presence

DR. BÄHLER DROPA compliance and trust

Trust signal

Compliance3 records

DR. BÄHLER DROPA financial estimates

Financial estimate

Revenue estimate

Valuation estimate

DR. BÄHLER DROPA leadership team

Management profile

Number of profiles

Profiles5 records

DR. BÄHLER DROPA subsidiaries and ownership

Company hierarchy

Subsidiaries2 records

DR. BÄHLER DROPA funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

DR. BÄHLER DROPA M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about DR. BÄHLER DROPA

What does DR. BÄHLER DROPA do?

DR. BÄHLER DROPA AG operates a network of approximately 120 pharmacies and drugstores across German-speaking Switzerland under the owned Achillea brand and the DROPA franchise brand, alongside the Schweizer Blisterzentrum which produces patient-individualized medication blister packaging in a Swissmedic-certified cleanroom. The company also delivers institutional pharmaceutical supply, blister packaging, and consulting services to nursing homes, Spitex organizations, prisons, assisted living facilities, and external pharmacies, supported by centralized purchasing, HR, quality assurance, marketing, and management services.

Is DR. BÄHLER DROPA a public or private company?

DR. BÄHLER DROPA is a private company. It is classified as family owned and is currently operating.

When was DR. BÄHLER DROPA founded?

DR. BÄHLER DROPA was founded in 1967. It employs 251 to 500 people.

Where is DR. BÄHLER DROPA based?

DR. BÄHLER DROPA is headquartered in Zürich, Switzerland, in the Europe region.

How does DR. BÄHLER DROPA make money?

Four revenue lines are on record. Retail Pharmacy and Drugstore Sales are the primary driver. The others are franchise Fees and Royalties, blister Packaging Services and institutional Medical Supplies.

Who are DR. BÄHLER DROPA's main competitors?

Direct peers on record are Amavita SA, Medbase AG, TopPharm AG, Sun Store SA, Well Apotheke (formerly Schlecker/Well) and Müller Drogeriemärkte (Müller Holding). Broad incumbents are BENU Apotheken (Phoenix Group) and Galenicare AG. Pharmaprix (Shoppers Drug Mart / Loblaw) is listed as an others. DocMorris AG (formerly Zur Rose) is listed as an emerging player.

Does DR. BÄHLER DROPA have an API?

No public API is recorded for DR. BÄHLER DROPA.

What industry is DR. BÄHLER DROPA in?

DR. BÄHLER DROPA's product category is Retail Pharmacy and Drugstore Services. Its primary akta.pro industry code is HLAFALAA, Retail & Community Pharmacies (Chain/Independent), with a secondary code of HLAFALAJ, Medication Adherence, Packaging & Fulfillment Services (Blister/Unit-Dose). Its NAICS code is 456110 and its SIC code is 5912.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales